David Eidinger
Impact in
- Immunology top 2%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune responses and vaccinations
- Surgery top 2%
- Bladder and Urothelial Cancer Treatments
Papers in
- Immunology 30
- T-cell and B-cell Immunology 22
- Complement system in diseases 6
- Mast cells and histamine 2
-
- Proteoglycans and glycosaminoglycans research 5
- Co-authors
- Álvaro Morales (6 shared papers)Andrew W. Bruce (3 shared papers)R. E. Glegg (5 shared papers)Thomas J. Garrett (1 shared paper)Robert S. Kerbel (6 shared papers)Hugh F. Pross (6 shared papers)C. P. Leblond (1 shared paper)Bram Rose (3 shared papers)
- Journals
- The Journal of Experimental Medicine (6 papers)Cellular Immunology (6 papers)The Journal of Urology (5 papers)Nature (3 papers)Science (2 papers)
- Partner nations
- Canada
In The Last Decade
David Eidinger
46 papers receiving 3.2k citations
David Eidinger's Hit Papers
Peers
Comparison fields: 5 of 112
- Immunology 1.1k
- Surgery 1.4k
- Anatomy 42
- Oncology 361
- Biotechnology 91
Countries citing papers authored by David Eidinger
This map shows the geographic impact of David Eidinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Eidinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Eidinger more than expected).
Fields of papers citing papers by David Eidinger
This network shows the impact of papers produced by David Eidinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Eidinger. The network helps show where David Eidinger may publish in the future.
Co-authors
The 25 scholars most cited alongside David Eidinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors Hit paper breakdown → | 1976 | 1436 |
| 2 | Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors Hit paper breakdown → | 2016 | 599 |
| 3 | 1972 | 277 | |
| 4 | 1957 | 184 | |
| 5 | 1972 | 121 | |
| 6 | 1974 | 111 | |
| 7 | 1953 | 95 | |
| 8 | 1971 | 81 | |
| 9 | 1954 | 72 | |
| 10 | 1964 | 61 | |
| 11 | 1976 | 60 | |
| 12 | 2002 | 57 | |
| 13 | 1972 | 55 | |
| 14 | 1977 | 48 | |
| 15 | 1967 | 42 | |
| 16 | 1972 | 42 | |
| 17 | 1968 | 40 | |
| 18 | 1962 | 39 | |
| 19 | 1954 | 35 | |
| 20 | 1971 | 27 |
About David Eidinger
David Eidinger is a scholar working on Immunology, Cell Biology, Surgery, Rheumatology and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 3.7k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (22 papers), Bladder and Urothelial Cancer Treatments (6 papers), Complement system in diseases (6 papers), Proteoglycans and glycosaminoglycans research (5 papers), Renal cell carcinoma treatment (3 papers), Asthma and respiratory diseases (2 papers), Mast cells and histamine (2 papers) and Polysaccharides and Plant Cell Walls (2 papers). The work is most often cited by research in Immunology (1.1k citations), Surgery (1.4k citations), Anatomy (42 citations), Oncology (361 citations) and Biotechnology (91 citations). David Eidinger has collaborated with scholars based in Canada. Frequent co-authors include Álvaro Morales, Andrew W. Bruce, R. E. Glegg, Thomas J. Garrett, Robert S. Kerbel, Hugh F. Pross, C. P. Leblond, Bram Rose, C. P. Leblond and Charles Philippe Leblond. Their work appears in journals such as The Journal of Experimental Medicine, Cellular Immunology, The Journal of Urology, Nature and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.